243 related articles for article (PubMed ID: 14500685)
41. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
42. CD8 epitope escape and reversion in acute HCV infection.
Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
[TBL] [Abstract][Full Text] [Related]
43. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.
Koibuchi T; Allen TM; Lichterfeld M; Mui SK; O'Sullivan KM; Trocha A; Kalams SA; Johnson RP; Walker BD
J Virol; 2005 Jul; 79(13):8171-81. PubMed ID: 15956562
[TBL] [Abstract][Full Text] [Related]
44. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
[TBL] [Abstract][Full Text] [Related]
45. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
46. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
Altfeld M; Allen TM; Yu XG; Johnston MN; Agrawal D; Korber BT; Montefiori DC; O'Connor DH; Davis BT; Lee PK; Maier EL; Harlow J; Goulder PJ; Brander C; Rosenberg ES; Walker BD
Nature; 2002 Nov; 420(6914):434-9. PubMed ID: 12459786
[TBL] [Abstract][Full Text] [Related]
47. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
48. Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen.
Peut V; Kent SJ
J Virol; 2007 Dec; 81(23):13125-34. PubMed ID: 17898063
[TBL] [Abstract][Full Text] [Related]
49. Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection.
Ndhlovu ZM; Kazer SW; Nkosi T; Ogunshola F; Muema DM; Anmole G; Swann SA; Moodley A; Dong K; Reddy T; Brockman MA; Shalek AK; Ndung'u T; Walker BD
Sci Transl Med; 2019 May; 11(493):. PubMed ID: 31118290
[TBL] [Abstract][Full Text] [Related]
50. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.
Gea-Banacloche JC; Migueles SA; Martino L; Shupert WL; McNeil AC; Sabbaghian MS; Ehler L; Prussin C; Stevens R; Lambert L; Altman J; Hallahan CW; de Quiros JC; Connors M
J Immunol; 2000 Jul; 165(2):1082-92. PubMed ID: 10878387
[TBL] [Abstract][Full Text] [Related]
51. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
52. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
[TBL] [Abstract][Full Text] [Related]
53. Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection.
Eller MA; Goonetilleke N; Tassaneetrithep B; Eller LA; Costanzo MC; Johnson S; Betts MR; Krebs SJ; Slike BM; Nitayaphan S; Rono K; Tovanabutra S; Maganga L; Kibuuka H; Jagodzinski L; Peel S; Rolland M; Marovich MA; Kim JH; Michael NL; Robb ML; Streeck H
J Virol; 2016 Apr; 90(8):4005-4016. PubMed ID: 26842474
[TBL] [Abstract][Full Text] [Related]
54. Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became Infected.
Boppana S; Fiore-Gartland A; Bansal A; Goepfert P
J Virol; 2020 Jan; 94(2):. PubMed ID: 31645444
[TBL] [Abstract][Full Text] [Related]
55. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection.
Geldmacher C; Gray C; Nason M; Currier JR; Haule A; Njovu L; Geis S; Hoffmann O; Maboko L; Meyerhans A; Cox J; Hoelscher M
J Virol; 2007 Dec; 81(24):13809-15. PubMed ID: 17898052
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection.
Alter G; Hatzakis G; Tsoukas CM; Pelley K; Rouleau D; LeBlanc R; Baril JG; Dion H; Lefebvre E; Thomas R; Côté P; Lapointe N; Routy JP; Sékaly RP; Conway B; Bernard NF
J Immunol; 2003 Jul; 171(1):477-88. PubMed ID: 12817033
[TBL] [Abstract][Full Text] [Related]
57. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
58. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
Bansal A; Gough E; Sabbaj S; Ritter D; Yusim K; Sfakianos G; Aldrovandi G; Kaslow RA; Wilson CM; Mulligan MJ; Kilby JM; Goepfert PA
AIDS; 2005 Feb; 19(3):241-50. PubMed ID: 15718834
[TBL] [Abstract][Full Text] [Related]
59. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.
Addo MM; Draenert R; Rathod A; Verrill CL; Davis BT; Gandhi RT; Robbins GK; Basgoz NO; Stone DR; Cohen DE; Johnston MN; Flynn T; Wurcel AG; Rosenberg ES; Altfeld M; Walker BD
PLoS One; 2007 Mar; 2(3):e321. PubMed ID: 17389912
[TBL] [Abstract][Full Text] [Related]
60. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
